C

Co-Diagnostics
D

CODX

0.73500
USD
0.03
(3.52%)
Market Open
Volume
500
EPS
-1
Div Yield
-
P/E
-1
Market Cap
23,468,368
OverviewSignalsIdeasNews
Related Instruments
    A
    APT
    -0.03000
    (-0.55%)
    5.44000 USD
    A
    AYTU
    0.09000
    (5.70%)
    1.67000 USD
    B
    BIOC
    -0.09610
    (-18.27%)
    0.42990 USD
    C
    CEMI
    0.02200
    (6.47%)
    0.35000 USD
    N
    NVAX
    0.02500
    (0.32%)
    7.95000 USD
    O
    OPK
    0.01000
    (0.68%)
    1.48000 USD
    Q
    QDEL
    0.810
    (1.84%)
    44.860 USD
    T
    TTOO
    0.00260
    (0.60%)
    0.43260 USD
    V
    VXRT
    0.01810
    (2.65%)
    0.70030 USD
    More
News

Title: Co/Diagnostics

Sector: Healthcare
Industry: Medical Devices
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detectionand/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.